Your browser doesn't support javascript.
loading
Long-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent Claudication.
Altin, S Elissa; Parise, Helen; Hess, Connie N; Rosenthal, Ning A; Creager, Mark A; Aronow, Herbert D; Curtis, Jeptha P.
Afiliação
  • Altin SE; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA; West Haven Veterans Affairs Medical Center, West Haven, Connecticut, USA. Electronic address: elissa.altin@yale.edu.
  • Parise H; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Hess CN; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA; Colorado Prevention Center Clinical Research, Aurora, Colorado, USA.
  • Rosenthal NA; Premier, Inc, PINC AI Applied Sciences, Charlotte, North Carolina, USA.
  • Creager MA; Heart and Vascular Center, Dartmouth-Hitchcock Medical Center and Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.
  • Aronow HD; Heart and Vascular, Henry Ford Health, Detroit, Michigan, USA.
  • Curtis JP; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA; Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut, USA.
JACC Cardiovasc Interv ; 16(13): 1668-1678, 2023 07 10.
Article em En | MEDLINE | ID: mdl-37438035
ABSTRACT

BACKGROUND:

In patients with intermittent claudication (IC), short-term amputation rates from clinical trial data following lower extremity femoropopliteal (FP) peripheral vascular intervention (PVI) are <1% with unknown longer-term rates.

OBJECTIVES:

The aim of this study was to identify revascularization and amputation rates following PVI in the FP segment and to assess 4-year amputation and revascularization rates after FP PVI for IC.

METHODS:

From 2016 to 2020, 19,324 patients undergoing FP PVI for IC were included from the PINC AI Healthcare Database and evaluated by treatment level (superficial femoral artery [SFA], popliteal artery [POP], or both). The primary outcome was index limb amputation (ILA) assessed by Kaplan-Meier estimate. The secondary outcomes were index limb major amputation and repeat revascularization. HRs were estimated using Cox proportional hazard regression.

RESULTS:

The 4-year index limb amputation rate following FP PVI was 4.3% (95% CI 4.0-4.7), with a major amputation rate of 3.2% (95% CI 2.9-3.5). After POP PVI, ILA was significantly higher than SFA alone (7.5% vs 3.4%) or both segment PVI (5.5%). In multivariate analysis, POP PVI was associated with higher ILA rates at 4 years compared with isolated SFA PVI (HR 2.10; 95% CI 1.52-2.91) and index limb major amputation (HR 1.98; 95% CI 1.32-2.95). Repeat FP revascularization rates were 15.2%; they were highest in patients undergoing both SFA and POP PVI (18.7%; P < 0.0001) compared with SFA (13.9%) and POP (17.1%) only.

CONCLUSIONS:

IC patients undergoing FP PVI had 4-year rates of index limb repeat revascularization of 16.7% and ILA rates of 4.3%. Further risk factors for amputation requires further investigation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artéria Femoral / Claudicação Intermitente Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artéria Femoral / Claudicação Intermitente Idioma: En Ano de publicação: 2023 Tipo de documento: Article